Anavex Life Sciences (AVXL) Short Interest Ratio & Short Volume → Top 5 AI Stocks to Buy for 2024 (From Market Moving Trends) (Ad) Free AVXL Stock Alerts $4.07 -0.05 (-1.21%) (As of 04/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Anavex Life Sciences Short Interest DataCurrent Short Volume22,120,000 sharesPrevious Short Volume20,000,000 sharesChange Vs. Previous Month+10.60%Dollar Volume Sold Short$112.59 millionShort Interest Ratio / Days to Cover17.3Last Record DateMarch 31, 2024Outstanding Shares82,110,000 sharesPercentage of Shares Shorted26.94%Today's Trading Volume1,333,696 sharesAverage Trading Volume1,426,896 sharesToday's Volume Vs. Average93% Short Selling Anavex Life Sciences ? Sign up to receive the latest short interest report for Anavex Life Sciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatAVXL Short Interest Over TimeAVXL Days to Cover Over TimeAVXL Percentage of Float Shorted Over Time Ad Paradigm PressCould Bitcoin Literally FORCE This Crypto To Rocket Up?Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…>>Click here to find out what it is. Anavex Life Sciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/202422,120,000 shares $112.59 million +10.6%N/A17.3 $5.09 3/15/202420,000,000 shares $102.20 million -0.1%N/A13.4 $5.11 2/29/202420,020,000 shares $102.90 million +0.7%N/A13.9 $5.14 2/15/202419,890,000 shares $115.96 million -1.2%N/A13.7 $5.83 1/31/202420,130,000 shares $120.18 million -2.6%N/A13.9 $5.97 1/15/202420,660,000 shares $123.75 million +2.9%N/A14.4 $5.99 Get the Latest News and Ratings for AVXL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Anavex Life Sciences and its competitors with MarketBeat's FREE daily newsletter. 12/31/202320,070,000 shares $186.85 million +10.8%N/A14.8 $9.31 12/15/202318,120,000 shares $160.18 million +0.8%N/A16.6 $8.84 11/30/202317,970,000 shares $129.56 million -0.8%N/A17.6 $7.21 11/15/202318,120,000 shares $111.98 million -2.6%N/A18.8 $6.18 10/31/202318,610,000 shares $103.84 million +4.5%N/A20.3 $5.58 10/15/202317,810,000 shares $107.75 million -0.9%N/A20.5 $6.05 9/30/202317,970,000 shares $117.70 million +5.2%N/A21.8 $6.55 9/15/202317,090,000 shares $129.37 million +1.2%N/A20.4 $7.57 8/31/202316,880,000 shares $133.35 million +1.0%N/A19.3 $7.90 8/15/202316,720,000 shares $149.48 million +1.1%N/A18.5 $8.94 7/31/202316,540,000 shares $136.46 million -1.1%N/A18.1 $8.25 7/15/202316,730,000 shares $140.87 million -0.1%N/A18.8 $8.42 6/30/202316,740,000 shares $136.10 million -5.6%N/A17.8 $8.13 6/15/202317,740,000 shares $156.64 million +7.5%N/A17.9 $8.83 5/31/202316,510,000 shares $152.55 million +3.8%N/A15.9 $9.24 5/15/202315,900,000 shares $150.89 million +10.6%N/A15.9 $9.49 4/30/202314,380,000 shares $117.05 million -7.8%N/A13.7 $8.14 4/15/202315,590,000 shares $122.85 million -1.9%N/A14.4 $7.88 3/31/202315,890,000 shares $136.18 million +1.3%N/A13.8 $8.57 3/15/202315,680,000 shares $146.76 million -3.9%N/A13.2 $9.36 2/28/202316,320,000 shares $155.37 million -4.7%N/A7.5 $9.52 2/15/202317,130,000 shares $179.35 million +2.5%N/A7.4 $10.47 1/31/202316,720,000 shares $181.75 million -9.0%N/A7.1 $10.87 1/15/202318,370,000 shares $194.35 million +0.7%N/A8.1 $10.58 12/30/202218,250,000 shares $169.00 million +15.7%N/A8.2 $9.26 12/15/202215,780,000 shares $131.76 million +32.5%N/A7.3 $8.35 11/30/202211,910,000 shares $105.05 million +17.1%N/A6 $8.82 11/15/202210,170,000 shares $142.89 million +0.6%N/A11.6 $14.05 10/31/202210,110,000 shares $123.04 million +0.7%N/A12.7 $12.17 10/15/202210,040,000 shares $106.42 million -2.1%N/A12.5 $10.60 9/30/202210,260,000 shares $105.88 million +5.3%N/A13 $10.32 9/15/20229,740,000 shares $92.63 million +7.0%N/A12.1 $9.51 8/31/20229,100,000 shares $87.27 million +8.0%N/A10.6 $9.59 8/15/20228,430,000 shares $100.06 million -3.4%N/A9.6 $11.87Could Bitcoin Literally FORCE This Crypto To Rocket Up? (Ad)Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…>>Click here to find out what it is. AVXL Short Interest - Frequently Asked Questions What is Anavex Life Sciences' current short interest? Short interest is the volume of Anavex Life Sciences shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 22,120,000 shares of AVXL short. Learn More on Anavex Life Sciences' current short interest. What is a good short interest ratio for Anavex Life Sciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AVXL shares currently have a short interest ratio of 17.0. Learn More on Anavex Life Sciences's short interest ratio. Which institutional investors are shorting Anavex Life Sciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Anavex Life Sciences: Wolverine Trading LLC, Citadel Advisors LLC, Point72 Asset Management L.P., PEAK6 Investments LLC, DLD Asset Management LP, UBS Group AG, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Anavex Life Sciences' short interest increasing or decreasing? Anavex Life Sciences saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 22,120,000 shares, an increase of 10.6% from the previous total of 20,000,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Anavex Life Sciences' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Anavex Life Sciences: TScan Therapeutics, Inc. (0.60%), MeiraGTx Holdings plc (1.79%), Tenaya Therapeutics, Inc. (4.99%), SOPHiA GENETICS SA (0.11%), Invivyd, Inc. (3.85%), Aura Biosciences, Inc. (6.17%), Caribou Biosciences, Inc. (12.85%), Jasper Therapeutics, Inc. (3.84%), Humacyte, Inc. (4.62%), Monte Rosa Therapeutics, Inc. (5.31%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Anavex Life Sciences stock? Short selling AVXL is an investing strategy that aims to generate trading profit from Anavex Life Sciences as its price is falling. AVXL shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Anavex Life Sciences? A short squeeze for Anavex Life Sciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AVXL, which in turn drives the price of the stock up even further. How often is Anavex Life Sciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AVXL, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: TCRX Short Interest Data MGTX Short Interest Data TNYA Short Interest Data SOPH Short Interest Data IVVD Short Interest Data AURA Short Interest Data CRBU Short Interest Data JSPR Short Interest Data HUMA Short Interest Data GLUE Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AVXL) was last updated on 4/18/2024 by MarketBeat.com Staff From Our Partners[Urgent!] Generational Wealth GameplanCrypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsThe “Perfect Storm” for GoldGold Safe ExchangeBiden out June 13; Kamala won’t replace him?Paradigm PressTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsUrgent alert: open this for a huge profit potentialTimothy SykesYour Money is Not SafeAmerican Alternative